Morning Briefing
Summaries of health policy coverage from major news organizations
FDA Panel Rejects Expansion Of Drug Label
The Food and Drug Administration panel rejected a bid to label two drugs as capable of reducing prostate cancer risk.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
